Article Details
Retrieved on: 2018-01-23 20:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Vaccitech, which came out of Oxford University, just received $27 million from investment firms Seqoia Capital and <b>Google Ventures</b>, among others, in support of its universal vaccine research. Another company, BiondVax, which hails from Israel, is entering phase 3 trials this coming fall. More than 9,000 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here